{ "uri": "https://www.find-tender.service.gov.uk/api/1.0/ocdsRecordPackages/ocds-h6vhtk-069d7c", "publisher": { "name": "Cabinet Office", "scheme": "GB-GOR", "uid": "D2", "uri": "https://www.gov.uk/government/organisations/cabinet-office" }, "publishedDate": "2026-11-09T13:41:31Z", "license": "http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "publicationPolicy": "https://www.gov.uk/government/publications/open-contracting", "version": "1.1", "extensions": [ "https://standard.open-contracting.org/profiles/eu/latest/en/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_amendment_rationale_classifications_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_budget_breakdown_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_contract_completion_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_documentation_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_pagination_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_suitability_extension/master/extension.json", "https://raw.githubusercontent.com/portaledcahn/ocds_Links_extension/main/extension.json", "https://raw.githubusercontent.com/cabinetoffice/ocds_uk_extension/main/extension.json" ], "packages": [ "https://www.find-tender.service.gov.uk/api/1.0/ocdsRecordPackages/ocds-h6vhtk-069d7c" ], "records": [ { "ocid": "ocds-h6vhtk-069d7c", "releases": [ { "ocid": "ocds-h6vhtk-069d7c", "id": "046401-2026", "tag": [ "planning" ], "date": "2026-05-20T13:59:26+01:00", "initiationType": "tender", "parties": [ { "name": "Healthcare Quality Improvement Partnership Ltd", "id": "GB-PPON-PVVQ-6113-CJWD", "identifier": { "scheme": "GB-PPON", "id": "PVVQ-6113-CJWD" }, "address": { "streetAddress": "128 City Road", "locality": "London", "postalCode": "EC1V 2NX", "country": "GB", "countryName": "United Kingdom", "region": "UKI43" }, "contactPoint": { "email": "procurement@hqip.org.uk", "telephone": "0000000000" }, "roles": [ "buyer" ], "details": { "classifications": [ { "scheme": "UK_CA_TYPE", "id": "publicAuthoritySubCentralGovernment", "description": "Public authority - sub-central government" } ] } } ], "buyer": { "id": "GB-PPON-PVVQ-6113-CJWD", "name": "Healthcare Quality Improvement Partnership Ltd" }, "planning": { "milestones": [ { "id": "engagement", "type": "engagement", "description": "Healthcare Quality Improvement Partnership (HQIP) is seeking to engage with the market on the recommissioning of the National Early Inflammatory Autoimmune Diseases Audit.\nThe Authority is looking to build on the successes of the existing audit currently contracted with the British Society for Rheumatology (BSR). Further information as well as details of the current audit can be found at: https://www.rheumatology.org.uk/improving-care/audits/neiaa\nHQIP will be looking to hold a pre-market engagement session with potential suppliers on Friday 3rd July 2026 12.00pm – 14.00pm.\nAlso in attendance will be system partners and service specialists including charities.\nThe aim of the pre market engagement session is for interested parties to hear and contribute to discussions with system experts and patient groups that will feed in to HQIP’s final decisions on the scope of the audit during this next contract period, and the anticipated outcomes over the 3-5 years of the audit.\nThe existing specification is available for review by any interested parties and whilst it will provide information on how the current audit was scoped, it is important to understand that the recommissioning of this audit may amend the requirements.\nAt this point, the Authority is planning to run this procurement under an open tender.\nThe proposed dates (subject to change solely at the Authorities discretion) are as follows:\n•3rd July 2026 - Pre Market Engagement Session\n•Publication of tender opportunity – October 2026\n•Evaluation of submitted bids – November – December 2026\n•Award – March 2027\n•Contract start - 1st October 2027\nWhilst the Authority intends to stick to the timeline, it may deviate away from it at any time.\nThe expected value of the contract will be subject to increase under aspirational intent measures which will be defined in the service specification at point of tender. \nThe aspirational intent will cover the value range and mechanisms for invoking each element of it.\nIf you would like to join this premarket engagement event, please register your interest at - https://forms.office.com/e/8wn8xiRwxt\nYou may also use this opportunity to request a copy of the existing project specification.", "dueDate": "2026-06-26T23:59:59+01:00", "status": "scheduled" } ], "documents": [ { "id": "046401-2026", "documentType": "marketEngagementNotice", "noticeType": "UK2", "description": "Preliminary market engagement notice on Find a Tender", "url": "https://www.find-tender.service.gov.uk/Notice/046401-2026", "datePublished": "2026-05-20T13:59:26+01:00", "format": "text/html" } ] }, "tender": { "id": "HQIP NCA 1008879041", "legalBasis": { "id": "2023/54", "scheme": "UKPGA", "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents" }, "title": "National Early Inflammatory Autoimmune Diseases Audit", "description": "The contract is expected to initially be delivered for NHS-funded care in England and Wales, and publicly funded care in Jersey for a period of three years, at a maximum total budget of up to £930,380.40 GBP including VAT and £775,317.00 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years as well as the option to include other Devolved Nations and/or Crown Dependencies, aspirational measures and discretionary inflationary uplifts (all of which will be defined in the service specification).\nThe maximum budget ‘core’ value of £930,380.40 GBP including VAT and £775,317.00 GBP excluding VAT, excludes the potential two-year extension and aspirational intent which will be included in the service specification at point of tender, meaning the ceiling value has the potential to be higher.\nDue to the unknowns in advance of holding the premarket engagement session, it is currently expected that the extension value will be a two-year pro rata of the core three- year funding, estimated at £516,878.00 excluding VAT.\nThis proposed extension value may also include pro rata funding of any additional aspirational measures invoked in the first three years of the contract. For example: If an aspirational annual requirement costing £500,000 per year is invoked in year three, then the extension funding (if the aspirational measure is continued) will be the above figures plus the additional £500,000 per year.\nFurther to this funding, the final specification will contain a list of aspirational measures which will be expected to be modified into the contract should the need and funding become available. The aspirational intent value, excluding the potential two- year extension, is unknown at point of drafting this notice, so, an estimated value of £7,000,000 excluding VAT is applied to form the maximum ceiling value AT POINT OF DRAFTING THIS NOTICE. This aspirational intent has the potential to be invoked fully, partially, or not at all, and the Authority cannot guarantee that the successful supplier will be required to do any of the aspirational measures that will be listed in the final specification.\nThe role of a national clinical audit is to stimulate healthcare improvement and reduce unwarranted variation through the provision of high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals providing the data can also improve the system, and there is a shared understanding of what good care looks like. \nThe National Early Inflammatory Autoimmune Diseases Audit, previously the National Early Inflammatory Arthritis Audit (NEIAA) was established in 2013 and since 2017 has been delivered by the British Society for Rheumatology (BSR) - https://www.rheumatology.org.uk/\nThe overarching aim is to stimulate improvements in care for patients by measuring variations in quality, experience and outcomes. During this contract period, the successful tenderer will need to build on the achievements of the audit to date and enhance the ability for the audit to be used for healthcare improvement. Data is most useful locally for healthcare improvement when its provision to clinical teams is timely, the data is refreshed regularly and appropriate tools, support and guidance accompany the data outputs. The intent is for all these features of the audit to be implemented and improved during the period of this contract. \nThe NEIAA should conform to the overarching aims and objective of all NCAPOP audits\nNational clinical audits are expected to: \na.Develop a robust, high-quality audit designed around key quality indicators likely to best support local and national quality improvement \nb.Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate \nc.Enable improvements through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health Board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting \nd.Engage service users, patients, parents, carers and families in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit \ne.Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future, and plan for these linkages from the inception of the contract \nf.Ensure robust methodological and statistical input at all stages of the audit \ng.Identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly \nh.Provide audit results in a timely, accessible and meaningful manner to support quality improvements, minimising the reporting delay and providing continual access to each unit for their own data \ni.Utilise strong and effective project and programme management to deliver audit outputs on time and within budget \nj.Develop and maintain strong engagement with local clinicians, networks, commissioners, parents and their families and carers and charity and community support groups in order to drive improvements in services. \nand in addition, the specific three -year data driven healthcare quality improvement aims are: \n1.Increase the proportion of people with immune-mediated inflammatory diseases (IMID) referred to rheumatology services within three working days \n2.For people with IMID reduce the delay in first rheumatology appointment, aiming to increase the proportion of patients seeing a rheumatologist within three weeks \n3.Shorten the time from referral to starting treatment for IMID, increasing the proportion of patients starting treatment within six weeks of referral \n4.Increase the proportion of patients receiving a holistic annual review \n5.Reduce diagnostic delay for patients with rare IMID \n6.Reduce diagnostic delay for patients with Axial Spondyloarthritis \n7.Reduce data collection burden for local clinical teams \nThe audit supplier will work with commissioners and funders to create a coherent strategy for how the improvement goals listed above, or similar, will support organisations in the rheumatology pathway to try and achieve them. See section 4 for further information on healthcare quality improvement. \nFurther details of the existing audit can be found at: https://www.rheumatology.org.uk/improving-care/audits/neiaa\nFor more information about this opportunity, please visit the eSourcing portal at: \nhttps://www.delta-esourcing.com/tenders/UK-UK-London:-Health-services./G355Y3Y9WC\nTo respond to this opportunity, please click here: \nhttps://www.delta-esourcing.com/respond/G355Y3Y9WC", "items": [ { "id": "1", "additionalClassifications": [ { "scheme": "CPV", "id": "85100000", "description": "Health services" } ], "deliveryAddresses": [ { "region": "UK", "country": "GB", "countryName": "United Kingdom" } ], "relatedLot": "1" } ], "value": { "amountGross": 9950633.5999999996, "amount": 8292195, "currency": "GBP" }, "mainProcurementCategory": "services", "aboveThreshold": true, "lots": [ { "id": "1", "contractPeriod": { "startDate": "2027-10-01T00:00:00+01:00", "endDate": "2030-09-30T23:59:59+01:00", "maxExtentDate": "2032-09-30T23:59:59+01:00" }, "hasRenewal": true, "status": "planning" } ], "communication": { "futureNoticeDate": "2026-10-01T23:59:59+01:00" }, "status": "planning" }, "language": "en", "extensions": [ "https://standard.open-contracting.org/profiles/eu/latest/en/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_amendment_rationale_classifications_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_budget_breakdown_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_contract_completion_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_documentation_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_pagination_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_suitability_extension/master/extension.json", "https://raw.githubusercontent.com/portaledcahn/ocds_Links_extension/main/extension.json", "https://raw.githubusercontent.com/cabinetoffice/ocds_uk_extension/main/extension.json" ] }, { "buyerID": [], "id": "092791-2026", "tag": [ "tender" ], "date": "2026-10-01T12:04:46+01:00", "initiationType": "tender", "ocid": "ocds-h6vhtk-069d7c", "parties": [ { "name": "Healthcare Quality Improvement Partnership Ltd", "id": "GB-PPON-PVVQ-6113-CJWD", "identifier": { "scheme": "GB-PPON", "id": "PVVQ-6113-CJWD" }, "address": { "streetAddress": "c/o Buzzacott LLP, 130 Wood Street", "locality": "London", "postalCode": "EC2V 6DL", "country": "GB", "countryName": "United Kingdom", "region": "UKI31" }, "contactPoint": { "email": "procurement@hqip.org.uk", "telephone": "0000000000" }, "roles": [ "buyer" ], "details": { "classifications": [ { "scheme": "UK_CA_TYPE", "id": "publicAuthoritySubCentralGovernment", "description": "Public authority - sub-central government" } ] } } ], "buyer": { "id": "GB-PPON-PVVQ-6113-CJWD", "name": "Healthcare Quality Improvement Partnership Ltd" }, "tender": { "id": "HQIP NCA 1008879041", "legalBasis": { "id": "2023/54", "scheme": "UKPGA", "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents" }, "title": "National Early Inflammatory Autoimmune Diseases Audit", "description": "The contract is expected to initially be delivered for NHS-funded care in England and Wales, and publicly funded care in Jersey for a period of three years, at a maximum total budget of up to £933,979.20 GBP including VAT and £778,316.00 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years as well as the option to include other Devolved Nations and/or Crown Dependencies, aspirational measures and discretionary inflationary uplifts (all of which will be defined in the service specification).\nThe maximum budget ‘core’ value of £933,979.20 GBP including VAT and £778,316.00 GBP excluding VAT, excludes the potential two-year extension and aspirational intent as included in section 14.4 of Annex A - Service Specification\nThe contract may be extended for up to 24 months at a pro rata value of the core three- year funding, estimated at up to £518,877 excluding VAT.\nThis proposed extension value may also include pro rata funding of any additional aspirational measures invoked in the first three years of the contract. For example: If an aspirational annual requirement costing £500,000 per year is invoked in year three, then the extension funding (if the aspirational measure is continued) will be the above figures plus the additional £500,000 per year.\nFurther to this funding, the specification contains a list of aspirational measures which will be expected to be modified into the contract should the need and funding become available. The aspirational intent value, including the potential two- year extension and core 3 year value means an overall ceiling value for this contract of up to £6,417,788 excluding VAT and £7,701,346 including VAT. This aspirational intent has the potential to be invoked fully, partially, or not at all, and the Authority cannot guarantee that the successful supplier will be required to do any of the aspirational measures listed in section 14.4 of Annex A - Service Specification\nThe role of a national clinical audit is to stimulate healthcare quality improvement through the provision of high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against available national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals who are engaging with and using the audit results are also in a position to improve the system, and where there is a shared understanding of what good care looks like.\nNational clinical audits are expected to:\na.Develop a robust, high-quality audit designed around key quality metrics likely to best support local and national healthcare quality improvement.\nb.Detect, describe and help reduce unwarranted clinical variation by systematically benchmarking performance, identifying outliers, and supporting services to understand variation in outcomes, processes and experience.\nc.Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate.\nd.Enable healthcare quality improvement through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting.\ne.Engage patients, carers and the public in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit.\nf.Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future and plan for these linkages from the inception of the contract.\ng.Ensure robust methodological and statistical input at all stages of the audit.\nh.Identify from the outset the full range of audiences for the reports and other audit outputs and plan and tailor them accordingly.\ni.Provide audit results in a timely, accessible and meaningful manner to support healthcare quality improvement, minimising the reporting delay and providing continual access to each unit for their own data.\nj.Utilise strong and effective project and programme management to deliver audit outputs on time and within budget.\nk.Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups to drive improvements in services.\nl.Deliver high-quality audit outputs, benchmarking and quality improvement as a priority. \nAt the time of writing the specification, requirements include (but please also refer to the potential future aspirational intent section):\n1. Audit Purpose\nThe overall ambition of the audit is to continue to capture and report data on the performance of individual healthcare providers against the National Institute for Health and Care Excellence (NICE) Quality Standard QS33: Rheumatoid Arthritis in Adults, Quality standard QS214: Rare diseases, and other relevant national standards and guidance, (see Appendix 1).\n2. Paediatric Inflammatory Arthritis Pathway\nThe supplier should work with the wider Dataset and Methodology Stakeholder Group to develop, maintain and report against a minimum viable paediatric inflammatory arthritis pathway. \nThe initial focus should be on establishing a clinically meaningful dataset and reporting framework sufficient to describe the patient pathway and support audit activity.\nInitial measures should focus on a limited number of priority areas agreed with funders and stakeholders, for example referral, diagnosis and treatment timelines.\nThe updated GIRFT Paediatric Inflammatory Arthritis Pathway guidance, anticipated for publication in January 2027, should be considered a key reference for the future development of the dataset, measures and reporting framework. The supplier should work with the wider Dataset and Methodology Stakeholder Group to review and align the dataset, metrics and reporting outputs with the recommendations and standards set out within the GIRFT guidance, ensuring ongoing relevance and consistency with national best practice.\nAny expansion beyond the core pathway, including additional metrics, PROMs/PREMs, transition measures and broader pathway development, should be considered future aspirational intent subject to feasibility, resources and further funding.\n3. Data Collection and Audit Design\nThe supplier should continue to deliver a continuous prospective clinical audit and work with the Dataset and Methodology Group to ensure the audit dataset remains clinically relevant and proportionate.\nThe supplier is expected to collaborate with specialist disease-specific clinical groups to support interpretation of findings and improve case ascertainment and recruitment rates.\n4. Organisational Survey and Quality Improvement\nThe supplier should review and maintain the organisational survey to ensure it remains proportionate and aligned with audit objectives. Priority should be given to maximising analysis and utilisation of existing data rather than increasing data collection burden in collaboration with the wider Dataset and Methodology Stakeholder Group.\nThe organisational survey should support the audit's quality improvement objectives by enabling a deeper understanding of service delivery, workforce capacity, variation in practice and barriers to high-quality care.\n5. Benchmarking and Improvement\nThe audit is expected to support continuous improvement across all services.\nWhile identifying high-performing and outlier services remains important, the audit should also support improvement among services performing at or around the national average, where the greatest overall gains may be achieved.\nBenchmarking should encourage year-on-year improvement within individual services and provide meaningful insights that motivate all providers to improve, regardless of their current position relative to national performance.\n6. Targeted improvement support\nThe supplier should provide targeted quality improvement support following each annual audit cycle. Activities should build on existing professional networks, collaboratives and stakeholder infrastructure wherever possible rather than creating wholly new arrangements.\nImprovement support should be designed to benefit healthcare providers across the performance spectrum, including those performing at a middle level where the greatest overall gains may be achieved, while also supporting services experiencing significant challenges or demonstrating exceptional practice.\nLearning generated through quality improvement activities should be shared with all participating healthcare providers to maximise the impact of the audit programme.\nThe anticipated outputs are:\n1.Near real-time dynamic and interactive metric results.\n2.Publication of an annual state of the nation report with the inclusion of an organisational survey.\n3.Incorporation of validated Patient Reported Outcome Measures.\n4.Quality improvement resources. \n5.The identification and notification of outliers.\nFor further information on the current audit, currently delivered by the British Society for Rheumatology (BSR) please head to: https://www.rheumatology.org.uk/improving-care/audits/neiaa", "status": "active", "items": [ { "id": "1", "additionalClassifications": [ { "scheme": "CPV", "id": "85100000", "description": "Health services" } ], "deliveryAddresses": [ { "region": "UK", "country": "GB", "countryName": "United Kingdom" } ], "relatedLot": "1" } ], "value": { "amountGross": 7701346, "amount": 6417788, "currency": "GBP" }, "procurementMethod": "open", "procurementMethodDetails": "Open procedure", "mainProcurementCategory": "services", "aboveThreshold": true, "submissionMethodDetails": "https://www.delta-esourcing.com/respond/G355Y3Y9WC", "submissionTerms": { "electronicSubmissionPolicy": "allowed", "languages": [ "en" ] }, "tenderPeriod": { "endDate": "2026-11-02T12:00:00+00:00" }, "enquiryPeriod": { "endDate": "2026-10-19T12:00:00+01:00" }, "awardPeriod": { "endDate": "2027-03-10T23:59:59+00:00" }, "lots": [ { "id": "1", "status": "active", "value": { "amountGross": 7701346, "amount": 6417788, "currency": "GBP" }, "awardCriteria": { "criteria": [ { "type": "quality", "name": "LEADERSHIP", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 4, "weight": "percentageExact" } ] }, { "type": "quality", "name": "ENGAGING AND INVOLVING PATIENTS, CARERS AND THE PUBLIC", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 10, "weight": "percentageExact" } ] }, { "type": "quality", "name": "STIMULATING HEALTHCARE QUALITY IMPROVEMENT", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 16, "weight": "percentageExact" } ] }, { "type": "quality", "name": "HEALTHCARE PROVIDER ENGAGEMENT, PARTICIPATION AND SUPPORT", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 5, "weight": "percentageExact" } ] }, { "type": "quality", "name": "DATA ACQUISITION STRATEGY AND BURDEN", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "INFORMATION GOVERNANCE", "description": "MAX WORD COUNT 250", "numbers": [ { "number": 4, "weight": "percentageExact" } ] }, { "type": "quality", "name": "DATA QUALITY AND ANALYSIS", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "USES OF THE DATA", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 9, "weight": "percentageExact" } ] }, { "type": "quality", "name": "PROGRAMME GOVERNANCE AND DELIVERY PLAN", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 10, "weight": "percentageExact" } ] }, { "type": "quality", "name": "RISK MANAGEMENT", "description": "MAX WORD COUNT 250", "numbers": [ { "number": 3, "weight": "percentageExact" } ] }, { "type": "cost", "name": "COST & ALLOCATION OF BUDGET", "description": "MAX WORD COUNT 250", "numbers": [ { "number": 5, "weight": "percentageExact" } ] }, { "type": "quality", "name": "SOCIAL VALUE 1", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 5, "weight": "percentageExact" } ] }, { "type": "quality", "name": "SOCIAL VALUE 2", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 5, "weight": "percentageExact" } ] } ] }, "suitability": { "sme": true, "vcse": true }, "contractPeriod": { "startDate": "2027-10-01T00:00:00+01:00", "endDate": "2030-09-30T23:59:59+01:00", "maxExtentDate": "2032-09-30T23:59:59+01:00" }, "hasRenewal": true, "renewal": { "description": "Up to 24 month extension at a value of up to £518,877 excluding VAT. This value also excludes any aspirational intent measures that may be invoked in advance of contract extension but intended to continue during the extension period. Therefore, this extension value is subject to significantly change based on any aspirational measures invoked." }, "description": null } ], "documents": [ { "id": "conflictOfInterest", "documentType": "conflictOfInterest", "description": "Not published" }, { "id": "A-23354", "documentType": "biddingDocuments", "url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-23354", "format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document" }, { "id": "A-23355", "documentType": "biddingDocuments", "url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-23355", "format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document" }, { "id": "092791-2026", "documentType": "tenderNotice", "noticeType": "UK4", "description": "Tender notice on Find a Tender", "url": "https://www.find-tender.service.gov.uk/Notice/092791-2026", "datePublished": "2026-10-01T12:04:46+01:00", "format": "text/html" } ], "contractTerms": { "financialTerms": "Invoicing will be paid quarterly in arrears. please refer to Annex B - HQIP template contract (long terms) - November 2025 for details on how the Authority deals with disputed invoices." }, "riskDetails": "The future aspirational intention of this opportunity including potential value, excluding VAT is to potentially include:\n•An extension period of up to 24 months - Up to £518,877 plus a pro-rata of any costs invoked under aspirational intent\n•Inclusion of additional clinical audits and/or clinical Outcome Review Programmes (CORP) - Up to £1,200,000\n•Transition to different models of data collection/outputs &/or operational methods/processes for the audit. This may include implementing new ways of working where opportunities emerge to leverage artificial intelligence tools to drive efficiency and reduce burden. - Up to £525,900\n•Extending specific service coverage to include privately funded care - Up to £300,000\n•Additions or enhancements to the service delivery of the project - Up to £1,000,000\n•Additional quality improvement initiatives either related to or linked with the project - Up to £300,000\n•Inclusion of additional national or international funders - Up to £794,695\n•Changes in line with national policy - Up to £300,000\n•Transition from children and young people (CYP) to adult services - Up to £300,000\n•Enhanced data linkages - Up to £300,000\n•Use of the NHS application for validated PROMs and PREMs - Up to £300,000\n•Expansion of CYP pathway metrics - Up to £300,000\nThe full list of aspirational intent as well as its indicative values and mechanisms for invoking, can be found under section 14.4 of Annex A – Service Specification\nPlease note, there is no commitment by the Authority at this stage to include any of these." }, "language": "en", "extensions": [ "https://standard.open-contracting.org/profiles/eu/latest/en/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_amendment_rationale_classifications_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_budget_breakdown_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_contract_completion_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_documentation_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_pagination_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_performance_failures_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_suitability_extension/master/extension.json", "https://raw.githubusercontent.com/portaledcahn/ocds_Links_extension/main/extension.json", "https://raw.githubusercontent.com/cabinetoffice/ocds_uk_extension/main/extension.json" ] }, { "buyerID": [], "id": "106242-2026", "tag": [ "tenderCancellation" ], "date": "2026-11-09T13:41:31Z", "initiationType": "tender", "ocid": "ocds-h6vhtk-069d7c", "parties": [ { "name": "Healthcare Quality Improvement Partnership Ltd", "id": "GB-PPON-PVVQ-6113-CJWD", "identifier": { "scheme": "GB-PPON", "id": "PVVQ-6113-CJWD" }, "address": { "streetAddress": "c/o Buzzacott LLP, 130 Wood Street", "locality": "London", "postalCode": "EC2V 6DL", "country": "GB", "countryName": "United Kingdom", "region": "UKI31" }, "contactPoint": { "email": "procurement@hqip.org.uk", "telephone": "0000000000" }, "roles": [ "buyer" ], "details": { "classifications": [ { "scheme": "UK_CA_TYPE", "id": "publicAuthoritySubCentralGovernment", "description": "Public authority - sub-central government" } ] } } ], "tender": { "id": "HQIP NCA 1008879041", "legalBasis": { "id": "2023/54", "scheme": "UKPGA", "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents" }, "title": "National Early Inflammatory Autoimmune Diseases Audit", "status": "complete", "lots": [ { "id": "1", "status": "complete" } ], "documents": [ { "id": "106242-2026", "documentType": "tenderCancellationNotice", "noticeType": "UK12", "description": "Procurement termination notice on Find a Tender", "url": "https://www.find-tender.service.gov.uk/Notice/106242-2026", "datePublished": "2026-11-09T13:41:31Z", "format": "text/html" } ] }, "awards": [ { "id": "1", "status": "cancelled", "statusDetails": "Following completion of the tender evaluation and clarification process, further information was identified regarding the scope, resourcing and commercial requirements associated with delivery of the service.\nHaving considered the position in the context of the procurement as a whole, the contracting authority has determined that it would not be appropriate to proceed to contract award under the current procurement process.\nThe procurement has therefore been terminated without award. The service requirements will now be reviewed before a decision is made regarding any future procurement.", "finalStatusDate": "2026-11-09T00:00:00+00:00", "relatedLots": [ "1" ] } ], "language": "en", "extensions": [ "https://standard.open-contracting.org/profiles/eu/latest/en/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_amendment_rationale_classifications_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_budget_breakdown_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_contract_completion_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_documentation_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_pagination_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_performance_failures_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_suitability_extension/master/extension.json", "https://raw.githubusercontent.com/portaledcahn/ocds_Links_extension/main/extension.json", "https://raw.githubusercontent.com/cabinetoffice/ocds_uk_extension/main/extension.json" ] } ], "compiledRelease": { "tag": [ "compiled" ], "id": "ocds-h6vhtk-069d7c-2026-11-09T13:41:31Z", "date": "2026-11-09T13:41:31Z", "ocid": "ocds-h6vhtk-069d7c", "initiationType": "tender", "parties": [ { "id": "GB-PPON-PVVQ-6113-CJWD", "name": "Healthcare Quality Improvement Partnership Ltd", "identifier": { "scheme": "GB-PPON", "id": "PVVQ-6113-CJWD" }, "address": { "streetAddress": "c/o Buzzacott LLP, 130 Wood Street", "locality": "London", "postalCode": "EC2V 6DL", "country": "GB", "countryName": "United Kingdom", "region": "UKI31" }, "contactPoint": { "email": "procurement@hqip.org.uk", "telephone": "0000000000" }, "roles": [ "buyer" ], "details": { "classifications": [ { "scheme": "UK_CA_TYPE", "id": "publicAuthoritySubCentralGovernment", "description": "Public authority - sub-central government" } ] } } ], "buyer": { "id": "GB-PPON-PVVQ-6113-CJWD", "name": "Healthcare Quality Improvement Partnership Ltd" }, "planning": { "milestones": [ { "id": "engagement", "type": "engagement", "description": "Healthcare Quality Improvement Partnership (HQIP) is seeking to engage with the market on the recommissioning of the National Early Inflammatory Autoimmune Diseases Audit.\nThe Authority is looking to build on the successes of the existing audit currently contracted with the British Society for Rheumatology (BSR). Further information as well as details of the current audit can be found at: https://www.rheumatology.org.uk/improving-care/audits/neiaa\nHQIP will be looking to hold a pre-market engagement session with potential suppliers on Friday 3rd July 2026 12.00pm – 14.00pm.\nAlso in attendance will be system partners and service specialists including charities.\nThe aim of the pre market engagement session is for interested parties to hear and contribute to discussions with system experts and patient groups that will feed in to HQIP’s final decisions on the scope of the audit during this next contract period, and the anticipated outcomes over the 3-5 years of the audit.\nThe existing specification is available for review by any interested parties and whilst it will provide information on how the current audit was scoped, it is important to understand that the recommissioning of this audit may amend the requirements.\nAt this point, the Authority is planning to run this procurement under an open tender.\nThe proposed dates (subject to change solely at the Authorities discretion) are as follows:\n•3rd July 2026 - Pre Market Engagement Session\n•Publication of tender opportunity – October 2026\n•Evaluation of submitted bids – November – December 2026\n•Award – March 2027\n•Contract start - 1st October 2027\nWhilst the Authority intends to stick to the timeline, it may deviate away from it at any time.\nThe expected value of the contract will be subject to increase under aspirational intent measures which will be defined in the service specification at point of tender. \nThe aspirational intent will cover the value range and mechanisms for invoking each element of it.\nIf you would like to join this premarket engagement event, please register your interest at - https://forms.office.com/e/8wn8xiRwxt\nYou may also use this opportunity to request a copy of the existing project specification.", "dueDate": "2026-06-26T23:59:59+01:00", "status": "scheduled" } ], "documents": [ { "id": "046401-2026", "documentType": "marketEngagementNotice", "noticeType": "UK2", "description": "Preliminary market engagement notice on Find a Tender", "url": "https://www.find-tender.service.gov.uk/Notice/046401-2026", "datePublished": "2026-05-20T13:59:26+01:00", "format": "text/html" } ] }, "tender": { "id": "HQIP NCA 1008879041", "legalBasis": { "id": "2023/54", "scheme": "UKPGA", "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents" }, "title": "National Early Inflammatory Autoimmune Diseases Audit", "description": "The contract is expected to initially be delivered for NHS-funded care in England and Wales, and publicly funded care in Jersey for a period of three years, at a maximum total budget of up to £933,979.20 GBP including VAT and £778,316.00 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years as well as the option to include other Devolved Nations and/or Crown Dependencies, aspirational measures and discretionary inflationary uplifts (all of which will be defined in the service specification).\nThe maximum budget ‘core’ value of £933,979.20 GBP including VAT and £778,316.00 GBP excluding VAT, excludes the potential two-year extension and aspirational intent as included in section 14.4 of Annex A - Service Specification\nThe contract may be extended for up to 24 months at a pro rata value of the core three- year funding, estimated at up to £518,877 excluding VAT.\nThis proposed extension value may also include pro rata funding of any additional aspirational measures invoked in the first three years of the contract. For example: If an aspirational annual requirement costing £500,000 per year is invoked in year three, then the extension funding (if the aspirational measure is continued) will be the above figures plus the additional £500,000 per year.\nFurther to this funding, the specification contains a list of aspirational measures which will be expected to be modified into the contract should the need and funding become available. The aspirational intent value, including the potential two- year extension and core 3 year value means an overall ceiling value for this contract of up to £6,417,788 excluding VAT and £7,701,346 including VAT. This aspirational intent has the potential to be invoked fully, partially, or not at all, and the Authority cannot guarantee that the successful supplier will be required to do any of the aspirational measures listed in section 14.4 of Annex A - Service Specification\nThe role of a national clinical audit is to stimulate healthcare quality improvement through the provision of high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against available national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals who are engaging with and using the audit results are also in a position to improve the system, and where there is a shared understanding of what good care looks like.\nNational clinical audits are expected to:\na.Develop a robust, high-quality audit designed around key quality metrics likely to best support local and national healthcare quality improvement.\nb.Detect, describe and help reduce unwarranted clinical variation by systematically benchmarking performance, identifying outliers, and supporting services to understand variation in outcomes, processes and experience.\nc.Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate.\nd.Enable healthcare quality improvement through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting.\ne.Engage patients, carers and the public in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit.\nf.Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future and plan for these linkages from the inception of the contract.\ng.Ensure robust methodological and statistical input at all stages of the audit.\nh.Identify from the outset the full range of audiences for the reports and other audit outputs and plan and tailor them accordingly.\ni.Provide audit results in a timely, accessible and meaningful manner to support healthcare quality improvement, minimising the reporting delay and providing continual access to each unit for their own data.\nj.Utilise strong and effective project and programme management to deliver audit outputs on time and within budget.\nk.Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups to drive improvements in services.\nl.Deliver high-quality audit outputs, benchmarking and quality improvement as a priority. \nAt the time of writing the specification, requirements include (but please also refer to the potential future aspirational intent section):\n1. Audit Purpose\nThe overall ambition of the audit is to continue to capture and report data on the performance of individual healthcare providers against the National Institute for Health and Care Excellence (NICE) Quality Standard QS33: Rheumatoid Arthritis in Adults, Quality standard QS214: Rare diseases, and other relevant national standards and guidance, (see Appendix 1).\n2. Paediatric Inflammatory Arthritis Pathway\nThe supplier should work with the wider Dataset and Methodology Stakeholder Group to develop, maintain and report against a minimum viable paediatric inflammatory arthritis pathway. \nThe initial focus should be on establishing a clinically meaningful dataset and reporting framework sufficient to describe the patient pathway and support audit activity.\nInitial measures should focus on a limited number of priority areas agreed with funders and stakeholders, for example referral, diagnosis and treatment timelines.\nThe updated GIRFT Paediatric Inflammatory Arthritis Pathway guidance, anticipated for publication in January 2027, should be considered a key reference for the future development of the dataset, measures and reporting framework. The supplier should work with the wider Dataset and Methodology Stakeholder Group to review and align the dataset, metrics and reporting outputs with the recommendations and standards set out within the GIRFT guidance, ensuring ongoing relevance and consistency with national best practice.\nAny expansion beyond the core pathway, including additional metrics, PROMs/PREMs, transition measures and broader pathway development, should be considered future aspirational intent subject to feasibility, resources and further funding.\n3. Data Collection and Audit Design\nThe supplier should continue to deliver a continuous prospective clinical audit and work with the Dataset and Methodology Group to ensure the audit dataset remains clinically relevant and proportionate.\nThe supplier is expected to collaborate with specialist disease-specific clinical groups to support interpretation of findings and improve case ascertainment and recruitment rates.\n4. Organisational Survey and Quality Improvement\nThe supplier should review and maintain the organisational survey to ensure it remains proportionate and aligned with audit objectives. Priority should be given to maximising analysis and utilisation of existing data rather than increasing data collection burden in collaboration with the wider Dataset and Methodology Stakeholder Group.\nThe organisational survey should support the audit's quality improvement objectives by enabling a deeper understanding of service delivery, workforce capacity, variation in practice and barriers to high-quality care.\n5. Benchmarking and Improvement\nThe audit is expected to support continuous improvement across all services.\nWhile identifying high-performing and outlier services remains important, the audit should also support improvement among services performing at or around the national average, where the greatest overall gains may be achieved.\nBenchmarking should encourage year-on-year improvement within individual services and provide meaningful insights that motivate all providers to improve, regardless of their current position relative to national performance.\n6. Targeted improvement support\nThe supplier should provide targeted quality improvement support following each annual audit cycle. Activities should build on existing professional networks, collaboratives and stakeholder infrastructure wherever possible rather than creating wholly new arrangements.\nImprovement support should be designed to benefit healthcare providers across the performance spectrum, including those performing at a middle level where the greatest overall gains may be achieved, while also supporting services experiencing significant challenges or demonstrating exceptional practice.\nLearning generated through quality improvement activities should be shared with all participating healthcare providers to maximise the impact of the audit programme.\nThe anticipated outputs are:\n1.Near real-time dynamic and interactive metric results.\n2.Publication of an annual state of the nation report with the inclusion of an organisational survey.\n3.Incorporation of validated Patient Reported Outcome Measures.\n4.Quality improvement resources. \n5.The identification and notification of outliers.\nFor further information on the current audit, currently delivered by the British Society for Rheumatology (BSR) please head to: https://www.rheumatology.org.uk/improving-care/audits/neiaa", "items": [ { "id": "1", "additionalClassifications": [ { "scheme": "CPV", "id": "85100000", "description": "Health services" } ], "deliveryAddresses": [ { "region": "UK", "country": "GB", "countryName": "United Kingdom" }, { "region": "UK", "country": "GB", "countryName": "United Kingdom" } ], "relatedLot": "1" } ], "value": { "amountGross": 7701346, "amount": 6417788, "currency": "GBP" }, "mainProcurementCategory": "services", "aboveThreshold": true, "lots": [ { "id": "1", "contractPeriod": { "startDate": "2027-10-01T00:00:00+01:00", "endDate": "2030-09-30T23:59:59+01:00", "maxExtentDate": "2032-09-30T23:59:59+01:00" }, "hasRenewal": true, "status": "complete", "value": { "amountGross": 7701346, "amount": 6417788, "currency": "GBP" }, "awardCriteria": { "criteria": [ { "type": "quality", "name": "LEADERSHIP", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 4, "weight": "percentageExact" } ] }, { "type": "quality", "name": "ENGAGING AND INVOLVING PATIENTS, CARERS AND THE PUBLIC", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 10, "weight": "percentageExact" } ] }, { "type": "quality", "name": "STIMULATING HEALTHCARE QUALITY IMPROVEMENT", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 16, "weight": "percentageExact" } ] }, { "type": "quality", "name": "HEALTHCARE PROVIDER ENGAGEMENT, PARTICIPATION AND SUPPORT", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 5, "weight": "percentageExact" } ] }, { "type": "quality", "name": "DATA ACQUISITION STRATEGY AND BURDEN", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "INFORMATION GOVERNANCE", "description": "MAX WORD COUNT 250", "numbers": [ { "number": 4, "weight": "percentageExact" } ] }, { "type": "quality", "name": "DATA QUALITY AND ANALYSIS", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "USES OF THE DATA", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 9, "weight": "percentageExact" } ] }, { "type": "quality", "name": "PROGRAMME GOVERNANCE AND DELIVERY PLAN", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 10, "weight": "percentageExact" } ] }, { "type": "quality", "name": "RISK MANAGEMENT", "description": "MAX WORD COUNT 250", "numbers": [ { "number": 3, "weight": "percentageExact" } ] }, { "type": "cost", "name": "COST & ALLOCATION OF BUDGET", "description": "MAX WORD COUNT 250", "numbers": [ { "number": 5, "weight": "percentageExact" } ] }, { "type": "quality", "name": "SOCIAL VALUE 1", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 5, "weight": "percentageExact" } ] }, { "type": "quality", "name": "SOCIAL VALUE 2", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 5, "weight": "percentageExact" } ] } ] }, "suitability": { "sme": true, "vcse": true }, "renewal": { "description": "Up to 24 month extension at a value of up to £518,877 excluding VAT. This value also excludes any aspirational intent measures that may be invoked in advance of contract extension but intended to continue during the extension period. Therefore, this extension value is subject to significantly change based on any aspirational measures invoked." } } ], "communication": { "futureNoticeDate": "2026-10-01T23:59:59+01:00" }, "status": "complete", "procurementMethod": "open", "procurementMethodDetails": "Open procedure", "submissionMethodDetails": "https://www.delta-esourcing.com/respond/G355Y3Y9WC", "submissionTerms": { "electronicSubmissionPolicy": "allowed", "languages": [ "en" ] }, "tenderPeriod": { "endDate": "2026-11-02T12:00:00+00:00" }, "enquiryPeriod": { "endDate": "2026-10-19T12:00:00+01:00" }, "awardPeriod": { "endDate": "2027-03-10T23:59:59+00:00" }, "documents": [ { "id": "conflictOfInterest", "documentType": "conflictOfInterest", "description": "Not published" }, { "id": "A-23354", "documentType": "biddingDocuments", "url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-23354", "format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document" }, { "id": "A-23355", "documentType": "biddingDocuments", "url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-23355", "format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document" }, { "id": "092791-2026", "documentType": "tenderNotice", "noticeType": "UK4", "description": "Tender notice on Find a Tender", "url": "https://www.find-tender.service.gov.uk/Notice/092791-2026", "datePublished": "2026-10-01T12:04:46+01:00", "format": "text/html" }, { "id": "106242-2026", "documentType": "tenderCancellationNotice", "noticeType": "UK12", "description": "Procurement termination notice on Find a Tender", "url": "https://www.find-tender.service.gov.uk/Notice/106242-2026", "datePublished": "2026-11-09T13:41:31Z", "format": "text/html" } ], "contractTerms": { "financialTerms": "Invoicing will be paid quarterly in arrears. please refer to Annex B - HQIP template contract (long terms) - November 2025 for details on how the Authority deals with disputed invoices." }, "riskDetails": "The future aspirational intention of this opportunity including potential value, excluding VAT is to potentially include:\n•An extension period of up to 24 months - Up to £518,877 plus a pro-rata of any costs invoked under aspirational intent\n•Inclusion of additional clinical audits and/or clinical Outcome Review Programmes (CORP) - Up to £1,200,000\n•Transition to different models of data collection/outputs &/or operational methods/processes for the audit. This may include implementing new ways of working where opportunities emerge to leverage artificial intelligence tools to drive efficiency and reduce burden. - Up to £525,900\n•Extending specific service coverage to include privately funded care - Up to £300,000\n•Additions or enhancements to the service delivery of the project - Up to £1,000,000\n•Additional quality improvement initiatives either related to or linked with the project - Up to £300,000\n•Inclusion of additional national or international funders - Up to £794,695\n•Changes in line with national policy - Up to £300,000\n•Transition from children and young people (CYP) to adult services - Up to £300,000\n•Enhanced data linkages - Up to £300,000\n•Use of the NHS application for validated PROMs and PREMs - Up to £300,000\n•Expansion of CYP pathway metrics - Up to £300,000\nThe full list of aspirational intent as well as its indicative values and mechanisms for invoking, can be found under section 14.4 of Annex A – Service Specification\nPlease note, there is no commitment by the Authority at this stage to include any of these." }, "language": "en", "extensions": [ "https://standard.open-contracting.org/profiles/eu/latest/en/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_amendment_rationale_classifications_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_budget_breakdown_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_contract_completion_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_documentation_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_pagination_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_performance_failures_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_suitability_extension/master/extension.json", "https://raw.githubusercontent.com/portaledcahn/ocds_Links_extension/main/extension.json", "https://raw.githubusercontent.com/cabinetoffice/ocds_uk_extension/main/extension.json" ], "awards": [ { "id": "1", "status": "cancelled", "statusDetails": "Following completion of the tender evaluation and clarification process, further information was identified regarding the scope, resourcing and commercial requirements associated with delivery of the service.\nHaving considered the position in the context of the procurement as a whole, the contracting authority has determined that it would not be appropriate to proceed to contract award under the current procurement process.\nThe procurement has therefore been terminated without award. The service requirements will now be reviewed before a decision is made regarding any future procurement.", "finalStatusDate": "2026-11-09T00:00:00+00:00", "relatedLots": [ "1" ] } ] }, "versionedRelease": { "ocid": "ocds-h6vhtk-069d7c", "initiationType": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "tender" } ], "parties": [ { "id": "GB-PPON-PVVQ-6113-CJWD", "name": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "Healthcare Quality Improvement Partnership Ltd" } ], "identifier": { "scheme": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "GB-PPON" } ], "id": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "PVVQ-6113-CJWD" } ] }, "address": { "streetAddress": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "128 City Road" }, { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "c/o Buzzacott LLP, 130 Wood Street" } ], "locality": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "London" } ], "postalCode": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "EC1V 2NX" }, { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "EC2V 6DL" } ], "country": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "GB" } ], "countryName": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "United Kingdom" } ], "region": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "UKI43" }, { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "UKI31" } ] }, "contactPoint": { "email": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "procurement@hqip.org.uk" } ], "telephone": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "0000000000" } ] }, "roles": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": [ "buyer" ] } ], "details": { "classifications": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": [ { "scheme": "UK_CA_TYPE", "id": "publicAuthoritySubCentralGovernment", "description": "Public authority - sub-central government" } ] } ] } } ], "buyer": { "id": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "GB-PPON-PVVQ-6113-CJWD" } ], "name": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "Healthcare Quality Improvement Partnership Ltd" } ] }, "planning": { "milestones": [ { "id": "engagement", "type": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "engagement" } ], "description": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "Healthcare Quality Improvement Partnership (HQIP) is seeking to engage with the market on the recommissioning of the National Early Inflammatory Autoimmune Diseases Audit.\nThe Authority is looking to build on the successes of the existing audit currently contracted with the British Society for Rheumatology (BSR). Further information as well as details of the current audit can be found at: https://www.rheumatology.org.uk/improving-care/audits/neiaa\nHQIP will be looking to hold a pre-market engagement session with potential suppliers on Friday 3rd July 2026 12.00pm – 14.00pm.\nAlso in attendance will be system partners and service specialists including charities.\nThe aim of the pre market engagement session is for interested parties to hear and contribute to discussions with system experts and patient groups that will feed in to HQIP’s final decisions on the scope of the audit during this next contract period, and the anticipated outcomes over the 3-5 years of the audit.\nThe existing specification is available for review by any interested parties and whilst it will provide information on how the current audit was scoped, it is important to understand that the recommissioning of this audit may amend the requirements.\nAt this point, the Authority is planning to run this procurement under an open tender.\nThe proposed dates (subject to change solely at the Authorities discretion) are as follows:\n•3rd July 2026 - Pre Market Engagement Session\n•Publication of tender opportunity – October 2026\n•Evaluation of submitted bids – November – December 2026\n•Award – March 2027\n•Contract start - 1st October 2027\nWhilst the Authority intends to stick to the timeline, it may deviate away from it at any time.\nThe expected value of the contract will be subject to increase under aspirational intent measures which will be defined in the service specification at point of tender. \nThe aspirational intent will cover the value range and mechanisms for invoking each element of it.\nIf you would like to join this premarket engagement event, please register your interest at - https://forms.office.com/e/8wn8xiRwxt\nYou may also use this opportunity to request a copy of the existing project specification." } ], "dueDate": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "2026-06-26T23:59:59+01:00" } ], "status": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "scheduled" } ] } ], "documents": [ { "id": "046401-2026", "documentType": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "marketEngagementNotice" } ], "noticeType": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "UK2" } ], "description": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "Preliminary market engagement notice on Find a Tender" } ], "url": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "https://www.find-tender.service.gov.uk/Notice/046401-2026" } ], "datePublished": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "2026-05-20T13:59:26+01:00" } ], "format": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "text/html" } ] } ] }, "tender": { "id": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "HQIP NCA 1008879041" } ], "legalBasis": { "id": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "2023/54" } ], "scheme": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "UKPGA" } ], "uri": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "https://www.legislation.gov.uk/ukpga/2023/54/contents" } ] }, "title": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "National Early Inflammatory Autoimmune Diseases Audit" } ], "description": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "The contract is expected to initially be delivered for NHS-funded care in England and Wales, and publicly funded care in Jersey for a period of three years, at a maximum total budget of up to £930,380.40 GBP including VAT and £775,317.00 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years as well as the option to include other Devolved Nations and/or Crown Dependencies, aspirational measures and discretionary inflationary uplifts (all of which will be defined in the service specification).\nThe maximum budget ‘core’ value of £930,380.40 GBP including VAT and £775,317.00 GBP excluding VAT, excludes the potential two-year extension and aspirational intent which will be included in the service specification at point of tender, meaning the ceiling value has the potential to be higher.\nDue to the unknowns in advance of holding the premarket engagement session, it is currently expected that the extension value will be a two-year pro rata of the core three- year funding, estimated at £516,878.00 excluding VAT.\nThis proposed extension value may also include pro rata funding of any additional aspirational measures invoked in the first three years of the contract. For example: If an aspirational annual requirement costing £500,000 per year is invoked in year three, then the extension funding (if the aspirational measure is continued) will be the above figures plus the additional £500,000 per year.\nFurther to this funding, the final specification will contain a list of aspirational measures which will be expected to be modified into the contract should the need and funding become available. The aspirational intent value, excluding the potential two- year extension, is unknown at point of drafting this notice, so, an estimated value of £7,000,000 excluding VAT is applied to form the maximum ceiling value AT POINT OF DRAFTING THIS NOTICE. This aspirational intent has the potential to be invoked fully, partially, or not at all, and the Authority cannot guarantee that the successful supplier will be required to do any of the aspirational measures that will be listed in the final specification.\nThe role of a national clinical audit is to stimulate healthcare improvement and reduce unwarranted variation through the provision of high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals providing the data can also improve the system, and there is a shared understanding of what good care looks like. \nThe National Early Inflammatory Autoimmune Diseases Audit, previously the National Early Inflammatory Arthritis Audit (NEIAA) was established in 2013 and since 2017 has been delivered by the British Society for Rheumatology (BSR) - https://www.rheumatology.org.uk/\nThe overarching aim is to stimulate improvements in care for patients by measuring variations in quality, experience and outcomes. During this contract period, the successful tenderer will need to build on the achievements of the audit to date and enhance the ability for the audit to be used for healthcare improvement. Data is most useful locally for healthcare improvement when its provision to clinical teams is timely, the data is refreshed regularly and appropriate tools, support and guidance accompany the data outputs. The intent is for all these features of the audit to be implemented and improved during the period of this contract. \nThe NEIAA should conform to the overarching aims and objective of all NCAPOP audits\nNational clinical audits are expected to: \na.Develop a robust, high-quality audit designed around key quality indicators likely to best support local and national quality improvement \nb.Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate \nc.Enable improvements through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health Board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting \nd.Engage service users, patients, parents, carers and families in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit \ne.Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future, and plan for these linkages from the inception of the contract \nf.Ensure robust methodological and statistical input at all stages of the audit \ng.Identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly \nh.Provide audit results in a timely, accessible and meaningful manner to support quality improvements, minimising the reporting delay and providing continual access to each unit for their own data \ni.Utilise strong and effective project and programme management to deliver audit outputs on time and within budget \nj.Develop and maintain strong engagement with local clinicians, networks, commissioners, parents and their families and carers and charity and community support groups in order to drive improvements in services. \nand in addition, the specific three -year data driven healthcare quality improvement aims are: \n1.Increase the proportion of people with immune-mediated inflammatory diseases (IMID) referred to rheumatology services within three working days \n2.For people with IMID reduce the delay in first rheumatology appointment, aiming to increase the proportion of patients seeing a rheumatologist within three weeks \n3.Shorten the time from referral to starting treatment for IMID, increasing the proportion of patients starting treatment within six weeks of referral \n4.Increase the proportion of patients receiving a holistic annual review \n5.Reduce diagnostic delay for patients with rare IMID \n6.Reduce diagnostic delay for patients with Axial Spondyloarthritis \n7.Reduce data collection burden for local clinical teams \nThe audit supplier will work with commissioners and funders to create a coherent strategy for how the improvement goals listed above, or similar, will support organisations in the rheumatology pathway to try and achieve them. See section 4 for further information on healthcare quality improvement. \nFurther details of the existing audit can be found at: https://www.rheumatology.org.uk/improving-care/audits/neiaa\nFor more information about this opportunity, please visit the eSourcing portal at: \nhttps://www.delta-esourcing.com/tenders/UK-UK-London:-Health-services./G355Y3Y9WC\nTo respond to this opportunity, please click here: \nhttps://www.delta-esourcing.com/respond/G355Y3Y9WC" }, { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "The contract is expected to initially be delivered for NHS-funded care in England and Wales, and publicly funded care in Jersey for a period of three years, at a maximum total budget of up to £933,979.20 GBP including VAT and £778,316.00 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years as well as the option to include other Devolved Nations and/or Crown Dependencies, aspirational measures and discretionary inflationary uplifts (all of which will be defined in the service specification).\nThe maximum budget ‘core’ value of £933,979.20 GBP including VAT and £778,316.00 GBP excluding VAT, excludes the potential two-year extension and aspirational intent as included in section 14.4 of Annex A - Service Specification\nThe contract may be extended for up to 24 months at a pro rata value of the core three- year funding, estimated at up to £518,877 excluding VAT.\nThis proposed extension value may also include pro rata funding of any additional aspirational measures invoked in the first three years of the contract. For example: If an aspirational annual requirement costing £500,000 per year is invoked in year three, then the extension funding (if the aspirational measure is continued) will be the above figures plus the additional £500,000 per year.\nFurther to this funding, the specification contains a list of aspirational measures which will be expected to be modified into the contract should the need and funding become available. The aspirational intent value, including the potential two- year extension and core 3 year value means an overall ceiling value for this contract of up to £6,417,788 excluding VAT and £7,701,346 including VAT. This aspirational intent has the potential to be invoked fully, partially, or not at all, and the Authority cannot guarantee that the successful supplier will be required to do any of the aspirational measures listed in section 14.4 of Annex A - Service Specification\nThe role of a national clinical audit is to stimulate healthcare quality improvement through the provision of high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against available national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals who are engaging with and using the audit results are also in a position to improve the system, and where there is a shared understanding of what good care looks like.\nNational clinical audits are expected to:\na.Develop a robust, high-quality audit designed around key quality metrics likely to best support local and national healthcare quality improvement.\nb.Detect, describe and help reduce unwarranted clinical variation by systematically benchmarking performance, identifying outliers, and supporting services to understand variation in outcomes, processes and experience.\nc.Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate.\nd.Enable healthcare quality improvement through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting.\ne.Engage patients, carers and the public in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit.\nf.Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future and plan for these linkages from the inception of the contract.\ng.Ensure robust methodological and statistical input at all stages of the audit.\nh.Identify from the outset the full range of audiences for the reports and other audit outputs and plan and tailor them accordingly.\ni.Provide audit results in a timely, accessible and meaningful manner to support healthcare quality improvement, minimising the reporting delay and providing continual access to each unit for their own data.\nj.Utilise strong and effective project and programme management to deliver audit outputs on time and within budget.\nk.Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups to drive improvements in services.\nl.Deliver high-quality audit outputs, benchmarking and quality improvement as a priority. \nAt the time of writing the specification, requirements include (but please also refer to the potential future aspirational intent section):\n1. Audit Purpose\nThe overall ambition of the audit is to continue to capture and report data on the performance of individual healthcare providers against the National Institute for Health and Care Excellence (NICE) Quality Standard QS33: Rheumatoid Arthritis in Adults, Quality standard QS214: Rare diseases, and other relevant national standards and guidance, (see Appendix 1).\n2. Paediatric Inflammatory Arthritis Pathway\nThe supplier should work with the wider Dataset and Methodology Stakeholder Group to develop, maintain and report against a minimum viable paediatric inflammatory arthritis pathway. \nThe initial focus should be on establishing a clinically meaningful dataset and reporting framework sufficient to describe the patient pathway and support audit activity.\nInitial measures should focus on a limited number of priority areas agreed with funders and stakeholders, for example referral, diagnosis and treatment timelines.\nThe updated GIRFT Paediatric Inflammatory Arthritis Pathway guidance, anticipated for publication in January 2027, should be considered a key reference for the future development of the dataset, measures and reporting framework. The supplier should work with the wider Dataset and Methodology Stakeholder Group to review and align the dataset, metrics and reporting outputs with the recommendations and standards set out within the GIRFT guidance, ensuring ongoing relevance and consistency with national best practice.\nAny expansion beyond the core pathway, including additional metrics, PROMs/PREMs, transition measures and broader pathway development, should be considered future aspirational intent subject to feasibility, resources and further funding.\n3. Data Collection and Audit Design\nThe supplier should continue to deliver a continuous prospective clinical audit and work with the Dataset and Methodology Group to ensure the audit dataset remains clinically relevant and proportionate.\nThe supplier is expected to collaborate with specialist disease-specific clinical groups to support interpretation of findings and improve case ascertainment and recruitment rates.\n4. Organisational Survey and Quality Improvement\nThe supplier should review and maintain the organisational survey to ensure it remains proportionate and aligned with audit objectives. Priority should be given to maximising analysis and utilisation of existing data rather than increasing data collection burden in collaboration with the wider Dataset and Methodology Stakeholder Group.\nThe organisational survey should support the audit's quality improvement objectives by enabling a deeper understanding of service delivery, workforce capacity, variation in practice and barriers to high-quality care.\n5. Benchmarking and Improvement\nThe audit is expected to support continuous improvement across all services.\nWhile identifying high-performing and outlier services remains important, the audit should also support improvement among services performing at or around the national average, where the greatest overall gains may be achieved.\nBenchmarking should encourage year-on-year improvement within individual services and provide meaningful insights that motivate all providers to improve, regardless of their current position relative to national performance.\n6. Targeted improvement support\nThe supplier should provide targeted quality improvement support following each annual audit cycle. Activities should build on existing professional networks, collaboratives and stakeholder infrastructure wherever possible rather than creating wholly new arrangements.\nImprovement support should be designed to benefit healthcare providers across the performance spectrum, including those performing at a middle level where the greatest overall gains may be achieved, while also supporting services experiencing significant challenges or demonstrating exceptional practice.\nLearning generated through quality improvement activities should be shared with all participating healthcare providers to maximise the impact of the audit programme.\nThe anticipated outputs are:\n1.Near real-time dynamic and interactive metric results.\n2.Publication of an annual state of the nation report with the inclusion of an organisational survey.\n3.Incorporation of validated Patient Reported Outcome Measures.\n4.Quality improvement resources. \n5.The identification and notification of outliers.\nFor further information on the current audit, currently delivered by the British Society for Rheumatology (BSR) please head to: https://www.rheumatology.org.uk/improving-care/audits/neiaa" } ], "items": [ { "id": "1", "additionalClassifications": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": [ { "scheme": "CPV", "id": "85100000", "description": "Health services" } ] } ], "deliveryAddresses": [ { "region": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "UK" } ], "country": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "GB" } ], "countryName": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "United Kingdom" } ] }, { "region": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "UK" } ], "country": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "GB" } ], "countryName": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "United Kingdom" } ] } ], "relatedLot": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "1" } ] } ], "value": { "amountGross": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": 9950633.5999999996 }, { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": 7701346 } ], "amount": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": 8292195 }, { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": 6417788 } ], "currency": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "GBP" } ] }, "mainProcurementCategory": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "services" } ], "aboveThreshold": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": true } ], "lots": [ { "id": "1", "contractPeriod": { "startDate": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "2027-10-01T00:00:00+01:00" } ], "endDate": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "2030-09-30T23:59:59+01:00" } ], "maxExtentDate": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "2032-09-30T23:59:59+01:00" } ] }, "hasRenewal": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": true } ], "status": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "planning" }, { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "active" }, { "releaseID": "106242-2026", "releaseDate": "2026-11-09T13:41:31Z", "releaseTag": [ "tenderCancellation" ], "value": "complete" } ], "value": { "amountGross": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": 7701346 } ], "amount": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": 6417788 } ], "currency": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "GBP" } ] }, "awardCriteria": { "criteria": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": [ { "type": "quality", "name": "LEADERSHIP", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 4, "weight": "percentageExact" } ] }, { "type": "quality", "name": "ENGAGING AND INVOLVING PATIENTS, CARERS AND THE PUBLIC", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 10, "weight": "percentageExact" } ] }, { "type": "quality", "name": "STIMULATING HEALTHCARE QUALITY IMPROVEMENT", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 16, "weight": "percentageExact" } ] }, { "type": "quality", "name": "HEALTHCARE PROVIDER ENGAGEMENT, PARTICIPATION AND SUPPORT", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 5, "weight": "percentageExact" } ] }, { "type": "quality", "name": "DATA ACQUISITION STRATEGY AND BURDEN", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "INFORMATION GOVERNANCE", "description": "MAX WORD COUNT 250", "numbers": [ { "number": 4, "weight": "percentageExact" } ] }, { "type": "quality", "name": "DATA QUALITY AND ANALYSIS", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "USES OF THE DATA", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 9, "weight": "percentageExact" } ] }, { "type": "quality", "name": "PROGRAMME GOVERNANCE AND DELIVERY PLAN", "description": "MAX WORD COUNT 750", "numbers": [ { "number": 10, "weight": "percentageExact" } ] }, { "type": "quality", "name": "RISK MANAGEMENT", "description": "MAX WORD COUNT 250", "numbers": [ { "number": 3, "weight": "percentageExact" } ] }, { "type": "cost", "name": "COST & ALLOCATION OF BUDGET", "description": "MAX WORD COUNT 250", "numbers": [ { "number": 5, "weight": "percentageExact" } ] }, { "type": "quality", "name": "SOCIAL VALUE 1", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 5, "weight": "percentageExact" } ] }, { "type": "quality", "name": "SOCIAL VALUE 2", "description": "MAX WORD COUNT 500", "numbers": [ { "number": 5, "weight": "percentageExact" } ] } ] } ] }, "suitability": { "sme": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": true } ], "vcse": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": true } ] }, "renewal": { "description": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "Up to 24 month extension at a value of up to £518,877 excluding VAT. This value also excludes any aspirational intent measures that may be invoked in advance of contract extension but intended to continue during the extension period. Therefore, this extension value is subject to significantly change based on any aspirational measures invoked." } ] }, "description": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": null } ] } ], "communication": { "futureNoticeDate": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "2026-10-01T23:59:59+01:00" } ] }, "status": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "planning" }, { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "active" }, { "releaseID": "106242-2026", "releaseDate": "2026-11-09T13:41:31Z", "releaseTag": [ "tenderCancellation" ], "value": "complete" } ], "procurementMethod": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "open" } ], "procurementMethodDetails": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "Open procedure" } ], "submissionMethodDetails": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "https://www.delta-esourcing.com/respond/G355Y3Y9WC" } ], "submissionTerms": { "electronicSubmissionPolicy": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "allowed" } ], "languages": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": [ "en" ] } ] }, "tenderPeriod": { "endDate": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "2026-11-02T12:00:00+00:00" } ] }, "enquiryPeriod": { "endDate": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "2026-10-19T12:00:00+01:00" } ] }, "awardPeriod": { "endDate": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "2027-03-10T23:59:59+00:00" } ] }, "documents": [ { "id": "conflictOfInterest", "documentType": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "conflictOfInterest" } ], "description": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "Not published" } ] }, { "id": "A-23354", "documentType": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "biddingDocuments" } ], "url": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-23354" } ], "format": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "application/vnd.openxmlformats-officedocument.wordprocessingml.document" } ] }, { "id": "A-23355", "documentType": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "biddingDocuments" } ], "url": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-23355" } ], "format": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "application/vnd.openxmlformats-officedocument.wordprocessingml.document" } ] }, { "id": "092791-2026", "documentType": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "tenderNotice" } ], "noticeType": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "UK4" } ], "description": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "Tender notice on Find a Tender" } ], "url": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "https://www.find-tender.service.gov.uk/Notice/092791-2026" } ], "datePublished": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "2026-10-01T12:04:46+01:00" } ], "format": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "text/html" } ] }, { "id": "106242-2026", "documentType": [ { "releaseID": "106242-2026", "releaseDate": "2026-11-09T13:41:31Z", "releaseTag": [ "tenderCancellation" ], "value": "tenderCancellationNotice" } ], "noticeType": [ { "releaseID": "106242-2026", "releaseDate": "2026-11-09T13:41:31Z", "releaseTag": [ "tenderCancellation" ], "value": "UK12" } ], "description": [ { "releaseID": "106242-2026", "releaseDate": "2026-11-09T13:41:31Z", "releaseTag": [ "tenderCancellation" ], "value": "Procurement termination notice on Find a Tender" } ], "url": [ { "releaseID": "106242-2026", "releaseDate": "2026-11-09T13:41:31Z", "releaseTag": [ "tenderCancellation" ], "value": "https://www.find-tender.service.gov.uk/Notice/106242-2026" } ], "datePublished": [ { "releaseID": "106242-2026", "releaseDate": "2026-11-09T13:41:31Z", "releaseTag": [ "tenderCancellation" ], "value": "2026-11-09T13:41:31Z" } ], "format": [ { "releaseID": "106242-2026", "releaseDate": "2026-11-09T13:41:31Z", "releaseTag": [ "tenderCancellation" ], "value": "text/html" } ] } ], "contractTerms": { "financialTerms": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "Invoicing will be paid quarterly in arrears. please refer to Annex B - HQIP template contract (long terms) - November 2025 for details on how the Authority deals with disputed invoices." } ] }, "riskDetails": [ { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": "The future aspirational intention of this opportunity including potential value, excluding VAT is to potentially include:\n•An extension period of up to 24 months - Up to £518,877 plus a pro-rata of any costs invoked under aspirational intent\n•Inclusion of additional clinical audits and/or clinical Outcome Review Programmes (CORP) - Up to £1,200,000\n•Transition to different models of data collection/outputs &/or operational methods/processes for the audit. This may include implementing new ways of working where opportunities emerge to leverage artificial intelligence tools to drive efficiency and reduce burden. - Up to £525,900\n•Extending specific service coverage to include privately funded care - Up to £300,000\n•Additions or enhancements to the service delivery of the project - Up to £1,000,000\n•Additional quality improvement initiatives either related to or linked with the project - Up to £300,000\n•Inclusion of additional national or international funders - Up to £794,695\n•Changes in line with national policy - Up to £300,000\n•Transition from children and young people (CYP) to adult services - Up to £300,000\n•Enhanced data linkages - Up to £300,000\n•Use of the NHS application for validated PROMs and PREMs - Up to £300,000\n•Expansion of CYP pathway metrics - Up to £300,000\nThe full list of aspirational intent as well as its indicative values and mechanisms for invoking, can be found under section 14.4 of Annex A – Service Specification\nPlease note, there is no commitment by the Authority at this stage to include any of these." } ] }, "language": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": "en" } ], "extensions": [ { "releaseID": "046401-2026", "releaseDate": "2026-05-20T13:59:26+01:00", "releaseTag": [ "planning" ], "value": [ "https://standard.open-contracting.org/profiles/eu/latest/en/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_amendment_rationale_classifications_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_budget_breakdown_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_contract_completion_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_documentation_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_pagination_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_suitability_extension/master/extension.json", "https://raw.githubusercontent.com/portaledcahn/ocds_Links_extension/main/extension.json", "https://raw.githubusercontent.com/cabinetoffice/ocds_uk_extension/main/extension.json" ] }, { "releaseID": "092791-2026", "releaseDate": "2026-10-01T12:04:46+01:00", "releaseTag": [ "tender" ], "value": [ "https://standard.open-contracting.org/profiles/eu/latest/en/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_amendment_rationale_classifications_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_budget_breakdown_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_contract_completion_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_documentation_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_pagination_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_performance_failures_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_suitability_extension/master/extension.json", "https://raw.githubusercontent.com/portaledcahn/ocds_Links_extension/main/extension.json", "https://raw.githubusercontent.com/cabinetoffice/ocds_uk_extension/main/extension.json" ] } ], "awards": [ { "id": "1", "status": [ { "releaseID": "106242-2026", "releaseDate": "2026-11-09T13:41:31Z", "releaseTag": [ "tenderCancellation" ], "value": "cancelled" } ], "statusDetails": [ { "releaseID": "106242-2026", "releaseDate": "2026-11-09T13:41:31Z", "releaseTag": [ "tenderCancellation" ], "value": "Following completion of the tender evaluation and clarification process, further information was identified regarding the scope, resourcing and commercial requirements associated with delivery of the service.\nHaving considered the position in the context of the procurement as a whole, the contracting authority has determined that it would not be appropriate to proceed to contract award under the current procurement process.\nThe procurement has therefore been terminated without award. The service requirements will now be reviewed before a decision is made regarding any future procurement." } ], "finalStatusDate": [ { "releaseID": "106242-2026", "releaseDate": "2026-11-09T13:41:31Z", "releaseTag": [ "tenderCancellation" ], "value": "2026-11-09T00:00:00+00:00" } ], "relatedLots": [ { "releaseID": "106242-2026", "releaseDate": "2026-11-09T13:41:31Z", "releaseTag": [ "tenderCancellation" ], "value": [ "1" ] } ] } ] } } ] }